文献速递关节外科

全膝关节置换术中在局部浸润镇痛基础上加用腘动脉与后膝关节囊之间浸润(IPACK)的前瞻性随机对照试验

Addition of Infiltration Between the Popliteal Artery and the Capsule of the Posterior Knee (IPACK) to Local Infiltration Analgesia for Total Knee Arthroplasty: A Prospective Randomized Controlled Trial.
PubMed 文献 · J Arthroplasty · 2023-01-20

120例初次全膝关节置换术患者随机分为LIA组、IPACK组和LIA+IPACK组,主要结局为VAS疼痛评分。IPACK单用组术后24小时内VAS评分显著高于LIA+IPACK组和LIA组;LIA+IPACK组在静息(12小时内)和屈曲(8小时内)时VAS评分低于LIA组;LIA+IPACK组和LIA组24小时内及住院期间吗啡当量均低于IPACK组。结论提示IPACK单用在疼痛控制方面较差。

要点

  • IPACK单用组术后24小时内VAS疼痛评分显著高于LIA+IPACK组和LIA组。
  • LIA+IPACK组静息12小时内和屈曲8小时内VAS评分低于LIA组。
  • LIA+IPACK组和LIA组24小时内及住院期间吗啡当量低于IPACK组。

核心结论

  • 该随机对照试验表明,与IPACK单用相比,LIA+IPACK和LIA的疼痛评分显著更低、阿片类药物用量更少、功能结果更好,提示IPACK单用在疼痛控制方面较差。

研究设计与样本

  • 前瞻性随机对照试验,共纳入120例接受初次全膝关节置换术的患者,随机分配至LIA组、IPACK组或LIA+IPACK组。

主要发现

  • IPACK单用组术后24小时内平均VAS疼痛评分显著高于LIA+IPACK组和LIA组(均P<.05)。
  • LIA+IPACK组在静息时(12小时内,P<.05)和屈曲时(8小时内,P<.05)的平均VAS疼痛评分低于LIA组。
  • LIA+IPACK组和LIA组24小时内吗啡当量分别为26.3和28.9,低于IPACK单用组的47.8(均P<.05);住院期间分别为98和101.6,低于IPACK单用组的128.4(均P<.05)。
  • 与IPACK单用组相比,LIA+IPACK组和LIA组在术后2天内ROM更高、12小时内肌力水平更高、1天内活动距离更长、至出院时TUG时间更短(均P<.05)。
  • LIA+IPACK组仅在术后第1天膝关节ROM高于LIA组(P<.05),其他结局均无显著差异。

关键数值与推荐

  • LIA组用药为50 mL 0.25%罗哌卡因和2.0 μg/mL肾上腺素;IPACK组用药为20 mL 0.25%罗哌卡因和2.0 μg/mL肾上腺素。
  • 主要结局为视觉模拟量表(VAS)疼痛评分。
  • 次要结局包括阿片类药物用量、膝关节活动度(ROM)、股四头肌肌力、活动距离、计时起立行走(TUG)试验和术后并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Local infiltration analgesia (LIA) is a popular analgesic technique commonly administered during total knee arthroplasty (TKA). Recent studies have demonstrated that the infiltration between the popliteal artery and the capsule of the posterior knee (IPACK) can be complementary to analgesic modalities. However, the combined and relative efficacy of LIA and IPACK is unclear. We aimed to evaluate the analgesic and functional outcomes among LIA, IPACK, and LIA + IPACK. METHODS: A total of 120 patients undergoing primary TKA were randomly allocated to 1 of 3 groups: LIA (50 mL of 0.25% ropivacaine and 2.0 μg/mL epinephrine); IPACK (20 mL of 0.25% ropivacaine and 2.0 μg/mL epinephrine); and LIA + IPACK. The primary outcome was the visual analog scale (VAS) pain score. Secondary outcomes were opioid use, knee range of motion (ROM), quadriceps muscle strength, mobilization distance, timed up and go (TUG) test, and postoperative complications. RESULTS: The mean VAS pain scores were significantly higher after using IPACK alone than after using LIA + IPACK and LIA within 24 hours (all P<.05). LIA + IPACK had lower mean VAS pain scores than LIA when the knees were at rest (within 12 hours, P < .05) and flexion (within 8 hours, P<.05). Patients receiving LIA + IPACK and LIA had significantly lower morphine equivalents (ME) than those receiving IPACK alone within 24 hours (26.3, 28.9 versus 47.8, both P<.05) and during hospitalization (98, 101.6, versus 128.4 both P<.05). Both LIA + IPACK and LIA had higher ROM (within 2 days), higher level of muscle strength (within 12 hours), longer mobilization distances (within 1 day), and shorter TUG time (till discharge) compared with IPACK alone (all P<.05), while LIA + IPACK only had a higher knee ROM than LIA on the first postoperative day (P<.05). There was no significant difference in any other outcomes. CONCLUSION: This randomized controlled trial demonstrated that there were significantly lower pain scores, less opioid consumption, and better functional results with LIA + IPACK and LIA when compared with IPACK alone, suggesting that IPACK alone was inferior for pain control.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Tang X, Wang D, Mou P, et al. Addition of Infiltration Between the Popliteal Artery and the Capsule of the Posterior Knee (IPACK) to Local Infiltration Analgesia for Total Knee Arthroplasty: A Prospective Randomized Controlled Trial. J Arthroplasty. 2023. PMID: 36690189. doi:10.1016/j.arth.2023.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。